Data / Form D filings / Windgap Medical, Inc.
Windgap Medical, Inc.: Form D filings
Windgap Medical, Inc., a pharmaceuticals company in Watertown, MA, filed 14 Form D notices with the SEC between 2014 and 2026. The latest, on January 26, 2026, reports $12.7 million sold of a $17.3 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 DEXTER AVENUE SUITE 270, Watertown, MA, 02472
- Phone
- (617) 440-3311
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1606077
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Amendment | $17,250,000 | $12,650,000 | $4,600,000 | 13 | Nov 6, 2023 | sec.gov |
| Nov 20, 2023 | New notice | $22,425,000 | $2,300,000 | $20,125,000 | 2 | Nov 6, 2023 | sec.gov |
| Jan 25, 2022 | Amendment | $42,169,754 | $39,151,781 | $3,017,973 | 46 | Aug 27, 2021 | sec.gov |
| Sep 9, 2021 | New notice | $32,142,326 | $17,001,923 | $15,140,403 | 30 | Aug 27, 2021 | sec.gov |
| Mar 16, 2020 | New notice | $2,000,000 | $360,500 | $1,639,500 | 20 | Feb 28, 2020 | sec.gov |
| Jan 17, 2019 | New notice | $39,017,359 | $12,151,193 | $26,866,166 | 106 | Jan 2, 2019 | sec.gov |
| Jul 9, 2018 | Amendment | $4,000,000 | $3,794,089 | $205,911 | 75 | May 1, 2017 | sec.gov |
| May 12, 2017 | New notice | $4,000,000 | $1,020,566 | $2,979,434 | 42 | May 1, 2017 | sec.gov |
| Apr 8, 2016 | New notice | $4,000,000 | $2,889,618 | $1,110,382 | 46 | Mar 25, 2016 | sec.gov |
| Aug 24, 2015 | Amendment | $4,500,000 | $4,221,097 | $278,903 | 92 | May 14, 2015 | sec.gov |
| Aug 14, 2015 | Amendment | $4,500,000 | $4,221,097 | $278,903 | 114 | May 14, 2015 | sec.gov |
| May 29, 2015 | New notice | $250,000 | $250,000 | 1 | May 14, 2015 | sec.gov | |
| May 29, 2015 | New notice | $4,500,000 | $3,713,875 | $786,125 | 86 | May 14, 2015 | sec.gov |
| Apr 24, 2014 | New notice | $2,717,500 | $1,494,500 | $1,223,000 | 56 | Apr 9, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Russell | Director | |
| John Reading Wilson | Director | |
| Timothy Krochuk | Director | |
| Brent Buchine | Director | |
| Aaron Mann | Executive Officer, Director | |
| Max Meehan | Executive Officer | |
| Jason Durkin | Executive Officer | |
| John Cadigan | Executive Officer | |
| Anthony Watson | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Windgap Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.